Spine Wave completed the limited market release of its Leva AF Interbody Device.
Spinal Tech
Colorado Springs, Colo.-based UCHealth Memorial Hospital joined InVivo Therapeutics' INSPIRE study as a clinical site.
Intellirod Spine secured over $1 million in equity financing from new and existing investors led by the OhioHealth Innovation Development Fund and Queen City Angel First Fund V.
The FDA cleared Spineology's Rampart One Anterior Lumbar Interbody Fusion System, according to Twin Cities Business.
K2M received FDA clearance for its Capri Small 3D Static Corpectomy System, a first-to-market 3D-printed corpectomy cage.
Advertisement
At its national sales meeting, ChoiceSpine launched its new biologics portfolio. ChoiceSpine specializes in developing spinal products.
InVivo Therapeutics enrolled another patient in its INSPIRE Study, testing the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.
The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.
The global spine biologics market will grow through 2024, based on a Transparency Market Research report, according to medGadget.
Jack Farr, MD, of Indianapolis-based OrthoIndy, performed the state's first meniscus replacement with Active Implants' NUsurface Meniscus Implant.